CN Patent

CN102014869A — 治疗或预防眼痛的酮咯酸氨丁三醇组合物

Assigned to Allergan Inc · Expires 2011-04-13 · 15y expired

What this patent protects

本发明提供含有有效量酮咯酸的眼用水溶液，其含有水溶液形式的羧甲基纤维素，其中选择所述羧甲基纤维素的浓度以使酮咯酸在患者眼中的吸收，较含有相同浓度酮咯酸的对比酮咯酸眼用水溶液的吸收，增加至少130％。

USPTO Abstract

本发明提供含有有效量酮咯酸的眼用水溶液，其含有水溶液形式的羧甲基纤维素，其中选择所述羧甲基纤维素的浓度以使酮咯酸在患者眼中的吸收，较含有相同浓度酮咯酸的对比酮咯酸眼用水溶液的吸收，增加至少130％。

Drugs covered by this patent

Patent Metadata

Patent number
CN102014869A
Jurisdiction
CN
Classification
—
Expires
2011-04-13
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.